Aerobic exercise for Breast Cancer

Phase-Based Progress Estimates
Breast Cancer+2 MoreAerobic exercise - Behavioral
What conditions do you have?

Study Summary

This trial will explore whether exercise can help protect the hearts of breast cancer patients receiving chemotherapy that is known to damage heart health.

Eligible Conditions
  • Breast Cancer
  • Cardiovascular Disease
  • Cardiotoxicity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Outcome will be assessed at baseline (week 0), post-intervention (week-13) and 6 months after the completion of the intervention.

Month 6
Change in Left Ventricular (LV) Function
Month 6
Change in Aerobic Fitness
Change in Blood biomarkers
Change in Fatigue
Change in Functional Assessment for Cancer Therapy
Month 6
Change in Cardiac Electrical Activity

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Aerobic exercise · No Placebo Group · N/A

Experimental Group · 1 Intervention: Aerobic exercise · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic exercise
Completed Phase 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: outcome will be assessed at baseline (week 0), post-intervention (week-13) and 6 months after the completion of the intervention.

Who is running the clinical trial?

Canadian Cancer Society (CCS)OTHER
71 Previous Clinical Trials
30,799 Total Patients Enrolled
5 Trials studying Breast Cancer
370 Patients Enrolled for Breast Cancer
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,233 Previous Clinical Trials
24,676,552 Total Patients Enrolled
9 Trials studying Breast Cancer
4,179 Patients Enrolled for Breast Cancer
Nova Scotia Health AuthorityLead Sponsor
233 Previous Clinical Trials
80,065 Total Patients Enrolled
3 Trials studying Breast Cancer
186 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be at least 18 years old to participate in this study.

Who else is applying?

What portion of applicants met pre-screening criteria?
Met criteria100.0%